Literature DB >> 11139023

Nisin-curvaticin 13 combinations for avoiding the regrowth of bacteriocin resistant cells of Listeria monocytogenes ATCC 15313.

A Bouttefroy1, J B Millière.   

Abstract

Nisin (25-100 IU/ml) and curvaticin 13 (160 AU/ml), a bacteriocin produced by Lactobacillus curvatus SB13, were shown to have a bactericidal effect against Listeria monocytogenes ATCC 15313 in TSB-YE broth (pH 6.5), but it was only transitory. Regrowth was not due to the loss of bacteriocin activity. Cells surviving nisin or curvaticin 13 were more resistant to the respective bacteriocin than the parental strain. Survivors to curvaticin 13 were resistant to the class IIa bacteriocins (camocin CP5, pediocin AcH) but remained sensitive to nisin. The frequencies of spontaneous nisin resistants decreased with increasing bacteriocin concentration and the presence of salts (NaCl, K2HPO4). The behaviour of nisin (1000 IU/ml) or curvaticin 13 (640 AU/ml) resistant variants (Nis1000, Curv645) was investigated in the presence of nisin (100 IU/ml) or curvaticin 13 (320 AU/ml) at 22 and 37 degrees C, and compared with that of the parental strain. The effectiveness of nisin was the same at both temperatures, whereas curvaticin 13 displayed a faster bactericidal action at 37 degrees C. Nis1000 cells were less sensitive to curvaticin 13 than the parental strain, whereas Curv640 cells were more sensitive to nisin than the parental strain. Simultaneous or sequential additions of nisin (50 IU/ml) and curvaticin 13 (160 AU/ml) were performed at 22 degrees C in broth inoculated with the parental strain. All combinations induced a greater inhibitory effect than the use of a single bacteriocin. Simultaneous addition of bacteriocins at t0 led to the absence of viable cells in the broth after 48 h.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11139023     DOI: 10.1016/s0168-1605(00)00372-x

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  7 in total

1.  Frequency of bacteriocin resistance development and associated fitness costs in Listeria monocytogenes.

Authors:  A Gravesen; A-M Jydegaard Axelsen; J Mendes da Silva; T B Hansen; S Knøchel
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

2.  pbp2229-mediated nisin resistance mechanism in Listeria monocytogenes confers cross-protection to class IIa bacteriocins and affects virulence gene expression.

Authors:  Anne Gravesen; Birgitte Kallipolitis; Kim Holmstrøm; Poul Erik Høiby; Manilduth Ramnath; Susanne Knøchel
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

3.  Differences in susceptibility of Listeria monocytogenes strains to sakacin P, sakacin A, pediocin PA-1, and nisin.

Authors:  T Katla; K Naterstad; M Vancanneyt; J Swings; L Axelsson
Journal:  Appl Environ Microbiol       Date:  2003-08       Impact factor: 4.792

4.  LAB Bacteriocins Controlling the Food Isolated (Drug-Resistant) Staphylococci.

Authors:  Jesús Perales-Adán; Susana Rubiño; Manuel Martínez-Bueno; Eva Valdivia; Manuel Montalbán-López; Rubén Cebrián; Mercedes Maqueda
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

Review 5.  A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier?

Authors:  Leon M T Dicks; Leané Dreyer; Carine Smith; Anton D van Staden
Journal:  Front Microbiol       Date:  2018-09-28       Impact factor: 5.640

6.  Potential of cell-free supernatants from cultures of selected lactic acid bacteria and yeast obtained from local fermented foods as inhibitors of Listeria monocytogenes, Salmonella spp. and Staphylococcus aureus.

Authors:  Solomon H Mariam; Nigus Zegeye; Tewodros Tariku; Emawayish Andargie; Nigatu Endalafer; Abraham Aseffa
Journal:  BMC Res Notes       Date:  2014-09-04

7.  Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations.

Authors:  Samira Soltani; Riadh Hammami; Paul D Cotter; Sylvie Rebuffat; Laila Ben Said; Hélène Gaudreau; François Bédard; Eric Biron; Djamel Drider; Ismail Fliss
Journal:  FEMS Microbiol Rev       Date:  2021-01-08       Impact factor: 16.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.